Table 2.
Who is Getting PrEP?
| Patient descriptives | Total cohort N = 825 | Qualitative N = 161 |
|---|---|---|
| White | 472 (56%) | 96 (60%) |
| Black | 167 (20%) | 29 (18%) |
| Latina/o | 123 (15%) | 18 (11%) |
| Native American or Asian American | 32 (4%) | 7 (4%) |
| Race/ethnicity not documented | 42 (5%) | 11 (7%) |
| Male | 801 (97%) | 146 (92%) |
| Female | 18 (2%) | 9 (5%) |
| Transgender | 7 (1%) | 6 (3%) |
| Mean age | 41.2 | 41.7 |
| Facilities in urban settings | 57 (54%) | 49 (54%) |
| HIV risk: MSM, MSMW | 698 (85%) | 119 (77%) |
| HIV risk: MSW | 64 (8%) | 5 (3%) |
| HIV risk: WSM, TSM | 25 (3%) | 15 (9%) |
| HIV risk: injection drug use | 13 (2%) | 10 (7%) |
| HIV risk factor not documented | 28 (4%) | 11 (7%) |
Transgender, includes trans men and trans women; MSM, men who have sex with men; WSM, women who have sex with men; TSM, Trans persons who have sex with men. Gender identity may not have been accurately captured in patient charts, so this figure may be an underestimate of actual numbers of transgender patients